Found: 21
Select item for more details and to access through your institution.
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 24, p. 2808, doi. 10.3390/cells12242808
- By:
- Publication type:
- Article
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational study.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1074044
- By:
- Publication type:
- Article
Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Control of flares and relief of urate burden with canakinumab and targeted urate-lowering therapy in tophaceous gouty arthritis.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Hepatitis B reactivation following treatment with abatacept in a patient with past hepatitis B virus infection.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2021, v. 60, n. 5, p. 2223, doi. 10.1093/rheumatology/keaa557
- By:
- Publication type:
- Article
Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study.
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02826-6
- By:
- Publication type:
- Article
Adaptation to inflammatory rheumatic disease: Do illness representations predict patients’ physical functioning over time? A complex relationship.
- Published in:
- Journal of Behavioral Medicine, 2018, v. 41, n. 2, p. 232, doi. 10.1007/s10865-017-9889-0
- By:
- Publication type:
- Article
The relation of partners' illness representations to the coping behaviors of patients with inflammatory rheumatic diseases through patients' illness representation: A dyadic regulation process.
- Published in:
- Current Psychology, 2023, v. 42, n. 20, p. 16923, doi. 10.1007/s12144-022-02937-y
- By:
- Publication type:
- Article
Patient and partner dispositional optimism as a long-term predictor of illness representations in autoimmune diseases.
- Published in:
- Journal of Health Psychology, 2017, v. 22, n. 13, p. 1691, doi. 10.1177/1359105316633287
- By:
- Publication type:
- Article
Emotion regulation contributes to the well-being of patients with autoimmune diseases through illness-related emotions: A prospective study.
- Published in:
- Journal of Health Psychology, 2020, v. 25, n. 13/14, p. 2096, doi. 10.1177/1359105318787010
- By:
- Publication type:
- Article
Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0775-2
- By:
- Publication type:
- Article
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample.
- Published in:
- Lupus, 2021, v. 30, n. 14, p. 2237, doi. 10.1177/09612033211061062
- By:
- Publication type:
- Article
Differential Expression of miR-4520a Associated With Pyrin Mutations in Familial Mediterranean Fever (FMF).
- Published in:
- Journal of Cellular Physiology, 2017, v. 232, n. 6, p. 1326, doi. 10.1002/jcp.25602
- By:
- Publication type:
- Article
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors?
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 21, p. 6945, doi. 10.3390/jcm12216945
- By:
- Publication type:
- Article
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11 , 4316.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 15, p. 4316, doi. 10.3390/jcm11154316
- By:
- Publication type:
- Article
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study.
- Published in:
- Rheumatology International, 2024, v. 44, n. 2, p. 249, doi. 10.1007/s00296-023-05455-7
- By:
- Publication type:
- Article
The effects of golimumab on patient centric outcomes amongst rheumatoid arthritis patients in Greece. The GO-Q study.
- Published in:
- Rheumatology International, 2022, v. 42, n. 4, p. 639, doi. 10.1007/s00296-021-05073-1
- By:
- Publication type:
- Article